FDA Adverse Event Injury Summary report: N

SYNVISC ONE

MDR report key: 4142569 · Received September 30, 2014

Report

Report Number
2246315-2014-32333
Event Type
Injury
Date Received
September 30, 2014
Date of Event
January 1, 2014
Report Date
September 23, 2014
Manufacturer
GENZYME BIOSURGERY (RIDGEFIELD)
Product Code
MOZ
PMA / PMN Number
P940015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PATIENT
Health Professional
Yes

Narratives

Description of Event or Problem · 1

THIS UNSOLICITED DEVICE CASE FROM UNITED STATES WAS RECEIVED ON (B)(6) 2014 FROM A PATIENT. THIS CASE INVOLVES AN (B)(6) MALE PATIENT WHOSE HAD LEFT KNEE PAIN AFTER RECEIVING TREATMENT WITH SYNVISC ONE. IT WAS REPORTED THAT THE PATIENT HAD NOT ACHIEVED THE PAIN RELIEF HE WAS HOPING. NO MEDICAL HISTORY, PAST DRUG, CONCOMITANT MEDICATION OR CONCURRENT CONDITION WAS REPORTED. ON AN UNKNOWN DATE IN 2014 (THREE WEEKS AGO) , THE PATIENT COMMENCED TREATMENT WITH SYNVISC ONE INJECTION AT A DOSE OF 6 ML ONCE (ROUTE, BATCH/ LOT NUMBER AND EXPIRATION DATE: NOT PROVIDED) INTO BOTH KNEES (BILATERAL INJECTIONS) FOR OSTEOARTHRITIS. ON AN UNKNOWN DATE IN 2014, THE RIGHT KNEE WAS DOING WELL, BUT THE LEFT KNEE WAS CAUSING THE PATIENT A GREAT DEAL OF PAIN. IT WAS REPORTED THAT THE PATIENT HAD NOT ACHIEVED THE PAIN RELIEF HE WAS HOPING (SUBTHERAPEUTIC RESPONSE) . THE PATIENT RECEIVED A CORTISONE INJECTION AND THAT RELIEF WAS APPROXIMATELY 2 WEEKS. OUTCOME: UNKNOWN FOR LEFT KNEE PAIN. SERIOUSNESS CRITERIA: REQUIRED INTERVENTION FOR LEFT KNEE PAIN A PHARMACEUTICAL TECHNICAL COMPLAINT (PTC) WAS INITIATED AND PTC RESULTS WERE PENDING. REPORTER CAUSALITY: NOT REPORTED. COMPANY CAUSALITY: POSSIBLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
608017 SYNVISC ONE INTRA-ARTICULAR HYALURONIC ACID MOZ GENZYME BIOSURGERY (RIDGEFIELD) UNK

Patients

Seq Age Sex Outcome Treatment
1 83 YR Male Required Intervention CON MEDS = UNKNOWN| PREV MEDS = UNKNOWN| CON MEDS =UNKNOWN| PREV MEDS =UNKNOWN